Literature DB >> 27897446

Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin.

J Vikse1, A Rygh2, K Kaisen3, R Omdal1,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27897446     DOI: 10.1080/03009742.2016.1241298

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  4 in total

1.  A case of rituximab-induced pyoderma gangrenosum.

Authors:  Jorge R Georgakopoulos; Gina Rohekar; Fiona E Lovegrove
Journal:  JAAD Case Rep       Date:  2018-10-29

Review 2.  Granulomatosis with Polyangiitis-Mimicking Advanced Gynecological Cancer: A Case Report and Systematic Review of the Literature.

Authors:  Augusto Pereira; Javier F Magrina; Paul M Magtibay; Beatriz G Stamps; Elena Muñoz-Nuñez; Tirso Perez-Medina
Journal:  J Pers Med       Date:  2022-02-16

3.  Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis.

Authors:  Annika Klumpp; Felix Luessi; Sinah Engel; Beate Weidenthaler-Barth; Detlef Becker; Stephan Grabbe; Hadrian Schepler
Journal:  JAAD Case Rep       Date:  2022-08-10

4.  Vulvovaginal pyoderma gangrenosum in association with rituximab.

Authors:  Catherine Maloney; Nicholas Blickenstaff; Aman Kugasia; Laura Beth Buford; Mark D Hoffman
Journal:  JAAD Case Rep       Date:  2018-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.